MX9201419A - Derivados de benzo isoxazol-piperidina. - Google Patents
Derivados de benzo isoxazol-piperidina.Info
- Publication number
- MX9201419A MX9201419A MX9201419A MX9201419A MX9201419A MX 9201419 A MX9201419 A MX 9201419A MX 9201419 A MX9201419 A MX 9201419A MX 9201419 A MX9201419 A MX 9201419A MX 9201419 A MX9201419 A MX 9201419A
- Authority
- MX
- Mexico
- Prior art keywords
- isoxazol
- piperidine
- benzo derivatives
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67691891A | 1991-03-28 | 1991-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9201419A true MX9201419A (es) | 1992-10-01 |
Family
ID=24716559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9201419A MX9201419A (es) | 1991-03-28 | 1992-03-30 | Derivados de benzo isoxazol-piperidina. |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP0646115B1 (es) |
JP (3) | JP2659107B2 (es) |
KR (1) | KR0179054B1 (es) |
CN (1) | CN1044242C (es) |
AT (1) | ATE231505T1 (es) |
AU (2) | AU658194B2 (es) |
BR (1) | BR9205811A (es) |
CA (2) | CA2195129C (es) |
CZ (1) | CZ289756B6 (es) |
DE (1) | DE69232907T2 (es) |
DK (1) | DK0646115T3 (es) |
EG (1) | EG20281A (es) |
ES (1) | ES2188584T3 (es) |
FI (1) | FI934223A0 (es) |
HU (1) | HU225047B1 (es) |
IE (1) | IE920980A1 (es) |
IL (3) | IL116122A (es) |
MX (1) | MX9201419A (es) |
MY (1) | MY108885A (es) |
NO (1) | NO304071B1 (es) |
NZ (3) | NZ242151A (es) |
PL (3) | PL170567B1 (es) |
PT (1) | PT100300B (es) |
RU (1) | RU2119920C1 (es) |
SG (1) | SG49055A1 (es) |
UA (1) | UA45944C2 (es) |
WO (1) | WO1992017475A1 (es) |
YU (1) | YU31392A (es) |
ZA (1) | ZA922239B (es) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750542A (en) * | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
EP0602242A4 (en) * | 1991-08-22 | 1994-06-29 | Yoshitomi Pharmaceutical | Benzisoxazole compound and use thereof. |
EP0535496A1 (en) * | 1991-09-25 | 1993-04-07 | Hoechst-Roussel Pharmaceuticals Incorporated | (1-Indanon-2yl)methylpiperidines, intermediates and a process for their preparation and their use as medicaments |
ATE232529T1 (de) * | 1992-11-23 | 2003-02-15 | Aventis Pharma Inc | Substituierte 3-(aminoalkylamino)-1,2- benzisoxazole und verwandte verbindungen |
US5494908A (en) * | 1992-11-23 | 1996-02-27 | Hoechst-Roussel Pharmaceutical Incorporated | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
GB9305623D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
WO1996013505A1 (en) * | 1994-10-26 | 1996-05-09 | Pfizer Inc. | PROCESSES AND INTERMEDIATES FOR PREPARING 5,7-DIHYDRO-3-[2-{1-BENZYLPIPERIDIN-4-YL}ETHYL]-6H-PYRROLO-[4,5-f]-1,2-BENZISOXAZOL-6-ONE |
JPH11500123A (ja) * | 1995-02-15 | 1999-01-06 | ファルマシア・アンド・アップジョン・カンパニー | CNSおよび心臓病の治療のためのイミダゾ[1,2−a]ピリジン類 |
EP0816362A4 (en) * | 1995-03-22 | 1998-07-08 | Taisho Pharmaceutical Co Ltd | THIAZOLE DERIVATIVES |
JP3057763B2 (ja) * | 1995-06-06 | 2000-07-04 | ヘキスト・マリオン・ルセル・インコーポレイテツド | 抗精神病薬としてのベンゾイソオキサゾール及びインダゾール誘導体 |
JPH09124643A (ja) * | 1995-08-14 | 1997-05-13 | Bristol Myers Squibb Co | 抗うつ作用を有する1−アリールアルキル−4−(アルコキシピリジニル)−又は4−(アルコキシピリミジニル)ピペラジン誘導体 |
US5916902A (en) * | 1995-09-13 | 1999-06-29 | Pfizer Inc. | Processes and intermediates for preparing 5, 7-dihydro-3- 2-(1-benzylpiperidin-4-yl)ethyl-!6H-pyrrolo- 4, 5-F!-1, 2-benzisoxazol-6-one |
US5998415A (en) * | 1995-11-02 | 1999-12-07 | Merck Sharp & Dohme Ltd. | Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation, and their use of as selective agonists of 5-HT1 -like receptors |
FR2751412B3 (fr) * | 1996-07-17 | 1998-09-25 | Valbiofrance | Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes |
US6013654A (en) * | 1997-08-14 | 2000-01-11 | Pharmacia & Upjohn Company | Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases |
EP0976404A3 (en) * | 1998-07-30 | 2001-06-27 | Pfizer Products Inc. | A pharmaceutical composition for the prevention and treatment of diseases of cognitive dysfunction in a mammal |
NZ510685A (en) | 1998-09-30 | 2003-10-31 | Takeda Chemical Industries Ltd | Drugs for improving vesical excretory strength |
EP1050303A3 (en) * | 1999-04-27 | 2003-01-15 | Pfizer Products Inc. | Methods and compositions for treating age-related behavioral disorders in companion animals |
US6951873B1 (en) | 1999-04-27 | 2005-10-04 | Pfizer Inc. | Methods for treating age-related behavioral disorders in companion animals |
EP1048302A3 (en) * | 1999-04-30 | 2002-07-17 | Pfizer Products Inc. | Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease |
GB9914486D0 (en) | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
GB9917408D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
GB9917406D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
US7091218B1 (en) | 1999-09-01 | 2006-08-15 | Eisai Co., Ltd. | 4-substituted piperidine compound |
US6906083B2 (en) | 2000-06-21 | 2005-06-14 | Eisai Co., Ltd. | 4-substituted piperidine compound |
EP1609783A1 (en) * | 2004-06-17 | 2005-12-28 | Neuropharma S.A.U. | Marine compounds with calcium channel blocking properties for Alzheimer's disease treatment |
DE102005038947A1 (de) * | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
US20090221644A1 (en) * | 2005-06-30 | 2009-09-03 | Stuart Edward Bradley | Gpcr Agonists |
GB0519879D0 (en) | 2005-09-30 | 2005-11-09 | Astrazeneca Ab | Chemical process |
WO2007126041A1 (ja) | 2006-04-28 | 2007-11-08 | Eisai R & D Management Co., Ltd. | ベンゾイソオキサゾール化合物 |
KR20100021633A (ko) * | 2007-06-01 | 2010-02-25 | 쉐링 코포레이션 | 감마 세크레타제 조절인자 |
US8008327B2 (en) | 2008-04-29 | 2011-08-30 | Boehringer Ingelheim International Gmbh | Indazole compounds as CCR1 receptor antagonists |
EP2297112B1 (en) | 2008-05-06 | 2013-04-03 | Boehringer Ingelheim International GmbH | Pyrazole compounds as ccr1 antagonists |
PE20110854A1 (es) | 2008-09-26 | 2011-12-23 | Boehringer Ingelheim Int | DERIVADOS DE 1-FENIL-1H-PIRAZOLO[3,4-c]PIRIDINA-4-CARBONILAMINA COMO ANTAGONISTAS DE LOS RECEPTORES CCR1 |
SI2376497T1 (sl) * | 2008-12-12 | 2014-01-31 | Actelion Pharmaceuticals Ltd. | Derivati 5-amino-2-(1-hidroksi-etil)-tetrahidropirana |
BR112012009331A2 (pt) | 2009-10-21 | 2019-09-24 | Boehringer Ingelheim Int | compostos de indazola e pirazolopiridina como antagonistas do receptor ccr1 |
US8927550B2 (en) | 2009-10-27 | 2015-01-06 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds as CCR1 receptor antagonists |
CA2789014C (en) | 2010-02-09 | 2019-01-15 | Michela Gallagher | Methods and compositions for improving cognitive function |
WO2011137109A1 (en) | 2010-04-30 | 2011-11-03 | Boehringer Ingelheim International Gmbh | Azaindazole amide compounds as ccr1 receptor antagonists |
WO2012087782A1 (en) | 2010-12-23 | 2012-06-28 | Boehringer Ingelheim International Gmbh | Pyrazolopiperidine compounds as ccr1 receptor antagonists |
EP3610890A1 (en) | 2012-11-14 | 2020-02-19 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
CN108658964B (zh) | 2012-11-21 | 2021-07-02 | 拉夸里亚创药株式会社 | 多晶型物 |
ES2881081T3 (es) | 2013-03-15 | 2021-11-26 | Agenebio Inc | Procedimientos y composiciones para mejorar la función cognitiva |
EP3827820A1 (en) | 2013-03-15 | 2021-06-02 | The Johns Hopkins University | Brivaracetam for improving cognitive function |
US10925834B2 (en) | 2015-05-22 | 2021-02-23 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
RU2638155C1 (ru) * | 2016-02-29 | 2017-12-12 | Общество С Ограниченной Ответственностью "Сай Фарма" | Производные бензо[d]изоксазола и их применение |
TW202321263A (zh) * | 2021-08-10 | 2023-06-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 磺醯胺衍生物、其製備方法及其在醫藥上的應用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3488353A (en) | 1967-05-29 | 1970-01-06 | Sterling Drug Inc | New 1-((2-azaindolyl)-lower-alkyl) 4-substituted-piperazines |
JPS51136666A (en) * | 1975-05-19 | 1976-11-26 | Dainippon Pharmaceut Co Ltd | Process for preparing 3-aminoalkyl-1,2-benzisoxazole derivatives. |
US4396770A (en) * | 1982-04-09 | 1983-08-02 | Hoechst-Roussel Pharmaceuticals Inc. | 1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines |
IL66866A (en) * | 1982-04-09 | 1987-08-31 | Hoechst Roussel Pharma | 1-(3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl)-4-(substituted)-piperazines and-piperidines,a process for the preparation thereof,and pharmaceutical compositions containing them |
US4489075A (en) * | 1982-05-15 | 1984-12-18 | Pfizer Inc. | Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants |
PH22302A (en) * | 1985-02-11 | 1988-07-22 | Fujisawa Pharmaceutical Co | Piperidine compounds |
DK623586A (da) * | 1985-12-27 | 1987-06-28 | Eisai Co Ltd | Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne |
JPS63234065A (ja) * | 1987-03-23 | 1988-09-29 | Mitsubishi Rayon Co Ltd | 包接能を有する高分子組成物 |
JPH0657707B2 (ja) * | 1987-05-25 | 1994-08-03 | 吉富製薬株式会社 | ピペリジン化合物 |
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
US4980365A (en) * | 1987-07-13 | 1990-12-25 | Hoechst-Roussel Pharmaceuticals Inc. | N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents |
ZA891113B (en) * | 1988-02-19 | 1990-10-31 | Lilly Co Eli | Tetrazole excitatory amino acid receptor antagonists |
JPH0283375A (ja) * | 1988-09-21 | 1990-03-23 | Dainippon Pharmaceut Co Ltd | 2−置換ピペラジニル−2−(1,2−ベンズイソキサゾール−3−イル)酢酸誘導体 |
FR2654104B1 (fr) * | 1989-11-07 | 1992-01-03 | Adir | Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
DE69231854T2 (de) * | 1991-04-17 | 2001-10-04 | Upjohn Co | Substituierte (s)-3-phenylpiperidin derivate, deren herstellung und deren verwendung als dopamin autorezeptor antagonisten |
-
1992
- 1992-03-09 PL PL92300711A patent/PL170567B1/pl not_active IP Right Cessation
- 1992-03-09 WO PCT/US1992/001605 patent/WO1992017475A1/en active IP Right Grant
- 1992-03-09 CZ CS19923958A patent/CZ289756B6/cs not_active IP Right Cessation
- 1992-03-09 RU RU93055137A patent/RU2119920C1/ru not_active IP Right Cessation
- 1992-03-09 CA CA002195129A patent/CA2195129C/en not_active Expired - Fee Related
- 1992-03-09 AT AT92921695T patent/ATE231505T1/de not_active IP Right Cessation
- 1992-03-09 ES ES92921695T patent/ES2188584T3/es not_active Expired - Lifetime
- 1992-03-09 AU AU18782/92A patent/AU658194B2/en not_active Ceased
- 1992-03-09 JP JP4510182A patent/JP2659107B2/ja not_active Expired - Fee Related
- 1992-03-09 EP EP92921695A patent/EP0646115B1/en not_active Expired - Lifetime
- 1992-03-09 CA CA002107105A patent/CA2107105C/en not_active Expired - Fee Related
- 1992-03-09 PL PL92313811A patent/PL171915B1/pl not_active IP Right Cessation
- 1992-03-09 HU HU9302733A patent/HU225047B1/hu not_active IP Right Cessation
- 1992-03-09 DE DE69232907T patent/DE69232907T2/de not_active Expired - Fee Related
- 1992-03-09 BR BR9205811A patent/BR9205811A/pt not_active Application Discontinuation
- 1992-03-09 UA UA93004393A patent/UA45944C2/uk unknown
- 1992-03-09 PL PL92313812A patent/PL171914B1/pl not_active IP Right Cessation
- 1992-03-09 DK DK92921695T patent/DK0646115T3/da active
- 1992-03-09 SG SG1996005572A patent/SG49055A1/en unknown
- 1992-03-22 IL IL11612292A patent/IL116122A/en active IP Right Grant
- 1992-03-22 IL IL11612295A patent/IL116122A0/xx unknown
- 1992-03-22 IL IL101327A patent/IL101327A/en active IP Right Grant
- 1992-03-26 EG EG15592A patent/EG20281A/xx active
- 1992-03-26 PT PT100300A patent/PT100300B/pt not_active IP Right Cessation
- 1992-03-27 IE IE098092A patent/IE920980A1/en not_active IP Right Cessation
- 1992-03-27 MY MYPI92000531A patent/MY108885A/en unknown
- 1992-03-27 CN CN92102178A patent/CN1044242C/zh not_active Expired - Fee Related
- 1992-03-27 NZ NZ242151A patent/NZ242151A/en not_active IP Right Cessation
- 1992-03-27 NZ NZ250987A patent/NZ250987A/en not_active IP Right Cessation
- 1992-03-27 NZ NZ248946A patent/NZ248946A/en not_active IP Right Cessation
- 1992-03-27 ZA ZA922239A patent/ZA922239B/xx unknown
- 1992-03-27 YU YU31392A patent/YU31392A/sh unknown
- 1992-03-30 MX MX9201419A patent/MX9201419A/es not_active IP Right Cessation
-
1993
- 1993-09-27 KR KR1019930702929A patent/KR0179054B1/ko not_active IP Right Cessation
- 1993-09-27 FI FI934223A patent/FI934223A0/fi not_active Application Discontinuation
- 1993-09-27 NO NO933445A patent/NO304071B1/no unknown
-
1995
- 1995-06-20 AU AU21788/95A patent/AU674477B2/en not_active Ceased
-
1997
- 1997-03-06 JP JP9052097A patent/JP3051076B2/ja not_active Expired - Fee Related
-
1999
- 1999-12-24 JP JP11368302A patent/JP2000154185A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9201419A (es) | Derivados de benzo isoxazol-piperidina. | |
NO944928D0 (no) | Fremgangsmåter for inhibering av Alzheimers sykdom | |
MX9102407A (es) | 4 arilpiperazinas y 4-arilpiperidinas novedosas. | |
FI914723A0 (fi) | 17b-substituerade 4-aza-5a-androstan -3-jon-derivat och foerfarande foer framstaellning av desamma. | |
FI96204C (fi) | Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi | |
FI895213A0 (fi) | Foereningar avsedda foer vaord av alzheimers sjukdom. | |
NO905157L (no) | Anlegg for behandling av borekaks. | |
NO924598L (no) | Fremstilling av substituerte piperidiner | |
NO880405D0 (no) | Fremgangsmaate til fremstilling av 3-fenyl-7h-tiazolo-/3,2-b//1,2,4/-tiazine-7-oner. | |
FI913414A (fi) | Foerfarande foer framstaellning av 2-hydroxi-3-halogen-5-nitropyridiner. | |
NO905643D0 (no) | Fremgangsmaate for behandling av manganslam. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |